Vera Therapeutics Grants 40,250 Options and 20,125 RSUs at $35.51 Exercise Price
On May 4, Vera’s compensation committee granted non-qualified stock options to purchase 40,250 shares and RSUs underlying 20,125 shares to ten new employees under its 2024 Inducement Plan. Options carry a $35.51 exercise price and vest over four years, with 25% at first anniversary and monthly thereafter.
1. Inducement Awards Granted
On May 4, 2026 the compensation committee granted inducement awards to ten new employees under the 2024 Inducement Plan, consisting of non-qualified stock options for 40,250 shares and restricted stock units for 20,125 shares.
2. Exercise Price and Vesting Terms
Each stock option carries an exercise price of $35.51 per share, equal to the closing price on the grant date; options vest over four years with 25% at the first anniversary and the remainder vesting monthly over 36 months. RSUs vest 25% annually over four years from May 20, 2026.
3. Nasdaq Rule Compliance
The awards were approved as material inducements to employment in compliance with Nasdaq Listing Rule 5635(c)(4), enabling the company to grant equity to new hires without prior shareholder approval.